Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors
2018 ◽
Vol 24
(4)
◽
pp. 455
◽
Johanna C. Bendell
◽
Manish R. Patel
◽
Kathleen N. Moore
◽
Cynthia C. Chua
◽
Hendrik‐Tobias Arkenau
◽
...
2014 ◽
Vol 20
(7)
◽
pp. 1900-1909
◽
Jordi Rodon
◽
Hussein A. Tawbi
◽
Anne L. Thomas
◽
Ronald G. Stoller
◽
Christian P. Turtschi
◽
...
2012 ◽
Vol 71
(2)
◽
pp. 463-471
◽
Raoul Tibes
◽
Gil Fine
◽
Gavin Choy
◽
Sanjeev Redkar
◽
Pietro Taverna
◽
...
2012 ◽
Vol 18
(9)
◽
pp. 2658-2667
◽
Klaus Mross
◽
Annette Frost
◽
Simone Steinbild
◽
Susanne Hedbom
◽
Martin Büchert
◽
...
2009 ◽
Vol 66
(4)
◽
pp. 669-680
◽
Francisco Robert
◽
Alan Sandler
◽
Joan H. Schiller
◽
Glenn Liu
◽
Karen Harper
◽
...
2014 ◽
Vol 74
(5)
◽
pp. 917-925
◽
Carlos R. Becerra
◽
Paul Conkling
◽
Nicholas Vogelzang
◽
Hilary Wu
◽
Shengyan Hong
◽
...
2014 ◽
Vol 20
(18)
◽
pp. 4747-4757
◽
Paul Haluska
◽
Michael Menefee
◽
Elizabeth R. Plimack
◽
Jonathan Rosenberg
◽
Donald Northfelt
◽
...
Todd Bauer
◽
David Hong
◽
Neeta Somaiah
◽
Charles Cai
◽
Saeheum Song
◽
...
Crystal S. Denlinger
◽
Vicki L. Keedy
◽
James M. Cleary
◽
William Kubasek
◽
Matthew Onsum
◽
...
Samuel C. Blackman
◽
Shelby D. Gainer
◽
Benjamin B. Suttle
◽
Konstantine W. Skordos
◽
Joel D. Greshock
◽
...
Rastislav Bahleda
◽
Funda Meric-Bernstam
◽
Lipika Goyal
◽
Ben Tran
◽
Helen He
◽
...
Close
Export Citation Format
Close
Share Document
Close